Search

Shop

Donate

Your heartHealthy livingFor professionalsResearchHow you can helpAbout us

Webinar: Pressure rising - Clinical controversies and updates in hypertension

Events

/

Webinar: Pressure rising - Clinical controversies and updates in hypertension

Hypertension is responsible for the largest burden of cardiovascular disease (CVD) in Australia.1 Even with gradual improvements in awareness and management, a significant proportion of hypertensive adults still fail to achieve recommended blood pressure (BP) targets.2  

Hosted live on World Heart Day 2021, this clinical webinar explores the latest evidence and controversies in BP management. Chaired by Prof. Garry Jennings, the expert discussion unpacks the latest clinical controversies in BP management including targets, resistant hypertension, and new digital technology for BP monitoring.

Duration: 1 hour

Year recorded: 2021

Topics covered:

  • Controversies in BP targets and implications for practice post SPRINT trial

  • Latest advice for the diagnosis and management of resistant hypertension

  • Latest advice on out-of-office blood pressure monitoring

  • Digital health tools on the horizon for CVD prevention and monitoring

  • Applying new evidence to clinical practice to promote structured CVD prevention strategies

Further reading and resources:

  • CVD Risk Guidelines

  • Hypertension clinical information and guidelines

Expert panelists

Prof. Rhian Touyz

Prof. Rhian Touyz (international speaker)

Executive Director and Chief Scientific Officer at the Research Institute of McGill University Health Centre, Montreal, Canada

Prof. Markus Schlaich

Prof. Markus Schlaich

Dobney Chair in Clinical Research at The University of Western Australia and President of High Blood Pressure Research Council of Australia

Prof. James Sharman

Prof. James Sharman

Deputy Director and Head of the Blood Pressure Research Group at the Menzies Institute for Medical Research, University of Tasmania

Prof. Nick Zwar

Prof. Nick Zwar

GP and Executive Dean of the Faculty of Health Sciences and Medicine at Bond University

This event was hosted in partnership with the World Heart Federation and the High Blood Pressure Research Council of Australia. 

World Heart Federation logo

The activity was funded by the Commonwealth Department of Health, as part of the Public Health and Chronic Disease program.

  1. Institute for Health Metrics and Evaluation 2018, Global Burden of Disease Study 2017 (GBD 2017) Results, Global Burden of Disease collective Network, Seattle, available from http://ghdx.healthdata.org/gbd-results-tool
  2. Hoare E, Kingwell BA, Jennings GLR. Blood Pressure Down Under, but Down Under What? US and Australian Hypertension Guideline Conversation. Hypertension. 2018;71(6):972-975. doi:10.1161/HYPERTENSIONAHA.118.11026.

You might also be interested in...

Doctor checking blood pressure of patient in clinic, risk of hypertension
Hypertension clinical information and guidelines

Clinical information for diagnosis and management of hypertension.

Webinar: Risky business – Understanding and managing residual CVD risk
Webinar: Risky business: Understanding and managing residual CVD risk

In recent decades, the management of modifiable risk factors, such as dyslipidaemia, hypertension and hyperglycaemia has undergone significant advancement.2 New and more aggressive pharmacotherapy regimes have driven treatment targets to levels not previously achievable and led to improvements in cardiovascular outcomes.

A novel anti-inflammatory approach to treat hypertension

Dr Chengxue Helena Qin, Monash University - 2019 Vanguard Grant

Last updated19 March 2024